OR56A3 c.477G>T ;(p.M159I)

Variant ID: 11-5969053-G-T

NM_001003443.2(OR56A3):c.477G>T;(p.M159I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: OR56A3: M159I
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page



Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy.

Oncotarget
Chen, Hui-Zi HZ; Bonneville, Russell R; Yu, Lianbo L; Wing, Michele R MR; Reeser, Julie W JW; Krook, Melanie A MA; Miya, Jharna J; Samorodnitsky, Eric E; Smith, Amy A; Martin, Dorrelyn D; Dao, Thuy T; Guo, Qishan Q; Liebner, David D; Freud, Aharon G AG; Allenby, Patricia P; Roychowdhury, Sameek S
Publication Date: 2019-01-08

Variant appearance in text: OR56A3: M159I
PubMed Link: 30719225
Variant Present in the following documents:
  • oncotarget-10-277-s002.xlsx, sheet 9
  • oncotarget-10-277-s002.xlsx, sheet 10
  • oncotarget-10-277-s002.xlsx, sheet 3
  • oncotarget-10-277-s002.xlsx, sheet 4
  • oncotarget-10-277-s006.xlsx, sheet 9
  • oncotarget-10-277-s002.xlsx, sheet 2
  • oncotarget-10-277-s002.xlsx, sheet 5
  • oncotarget-10-277-s002.xlsx, sheet 8
  • oncotarget-10-277-s002.xlsx, sheet 6
  • oncotarget-10-277-s002.xlsx, sheet 1
  • oncotarget-10-277-s002.xlsx, sheet 7
View BVdb publication page